Andrew Grieve is the CEO of Zenabis and he joined Business of Cannabis to talk about their agreement to grow Tantalus Labs genetics on contract as well as their stock offering to current shareholders – which has been the topic of conversation among those that follow publicly traded cannabis companies.
Hawaii Lawmakers Shoot Down Second Cannabis Reform Bill This Month
Hawaii lawmakers have shot down another attempt at cannabis reform, just weeks after a landmark legalization bill was killed in...